HIGHLIGHTS
- who: Chao Liang from the POCT application with clinical samples collected on site To validate FAST-POCT`s clinical applicability, we tested , clinical samples (nasal swab samples) from patients (n=18) with IBV and control individuals (n=18) without IBV (Fig6a). Patient information is available in Supplementary Table, . IBV infection status was independently confirmed and the study protocols were approved by The First Affiliated Hospital of Zhejiang University (Hangzhou, Zhejiang). Each patient sample was divided into two categories. One aliquot was processed using the FAST-POCT and the other using a benchtop PCR system (SLAN- P, China . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.